Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

BACKGROUND: Mesenchymal stem cell (MSC) transplantation is a fast-developing therapy in regenerative medicine. However, some concerns have been raised regarding their safety and the infusion-related pro-coagulant activity. The aim of this study is to analyze the induced thrombogenic risk and the saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppin, Louise C. F., Smets, Françoise, Ambroise, Jérome, Sokal, Etienne E. M., Stéphenne, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006410/
https://www.ncbi.nlm.nih.gov/pubmed/32028991
http://dx.doi.org/10.1186/s13287-020-1572-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006410/
https://www.ncbi.nlm.nih.gov/pubmed/32028991
http://dx.doi.org/10.1186/s13287-020-1572-7

Ejemplares similares